Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - tezepelumab
Get the latest updates from Google Alert - tezepelumab directly as they happen.
Follow now 112 followers
Latest posts
Last updated about 5 hours ago
Tezepelumab ottiene l'approvazione in Europa per la poliposi nasale - FarmaciaVirtuale.it
about 10 hours ago
Tezepelumab è un anticorpo monoclonale first-in-class che agisce inibendo la linfopoietina timica...
速递丨瑞博生物治疗丁型肝炎新型小核酸药物荣获EMA孤儿药认证 - 新药情报库
about 12 hours ago
10月24日，瑞博生物及其子公司Ribocure Pharmaceuticals（简称“Ribocure”）联合宣布，其小干扰RNA（siRNA）候选药物RBD1016已获得欧洲药品管理局（EMA）授予的孤儿药 ...
青少年银屑病治疗迎来新突破：Icotrokinra临床试验揭示疗效亮点 - 新药情报库
about 12 hours ago
近期，强生公司发布了一项令人振奋的研究成果，这项涉及青少年银屑病患者的临床试验或许将为该群体带来新的治疗契机。银屑病不仅使青少年承受皮肤不适， ...
赛诺菲1类创新药首获国内临床试验批准 - 新药情报库
about 12 hours ago
10月22日，据CDE官网消息，赛诺菲公司开发的SAR446523注射剂首次在国内获准进行临床试验，适应症为复发或难治性多发性骨髓瘤患者。值得注意的是，SAR446523是 ...
赛诺菲幼儿RSV疫苗三期试验未达标，疗效折戟沉沙 - 新药情报库
about 12 hours ago
2025年10月24日，法国制药公司赛诺菲宣布停止对幼儿呼吸道合胞病毒（RSV）疫苗SP0125的研发。SP0125曾被视为一项突破性进展，是专门为幼儿设计的首款经鼻给药减 ...
远大医药全球创新眼科药物GPN00884在中国IIa期临床研究首例患者成功入组
about 12 hours ago
点击本文中加粗蓝色字体即可一键直达新药情报库免费查阅文章里提到的药物、机构、靶点、适应症的最新研发进展。 远大医药宣布，针对儿童近视推迟的新型眼科 ...
Asthma control improves with tezepelumab, reduced oral corticosteroid use - Healio
about 12 hours ago
... tezepelumab, according to an abstract presented at CHEST 2025.These improvements followed...
Tezepelumab agisce al cuore dell'infiammazione nella poliposi nasa - Pharmastar
about 22 hours ago
Al congresso ERS 2025 di Amsterdam e stata presentata una sottoanalisi dello...
Relationships of type 2 biomarkers with spirometry in response to tezepelumab in ...
2 days ago
Here, we assessed the effects of tezepelumab on spirometry outcomes of large...
Rinosinusite cronica con poliposi nasale, ok Ue a monoclonale tezepelumab - eventi.news
2 days ago
(Adnkronos) - L'approvazione si basa sui risultati dello studio di fase 3...
首款重磅ADC！葛兰素史克新药正式在美国上市批准
2 days ago
10月23日，葛兰素史克（GSK）宣布其创新药物BCMA ADC——玛贝兰妥单抗（Belantamab mafodotin）成功获得美国食品药品监督管理局（FDA）的正式批准。
通化东宝门冬胰岛素注射液获批境外药品注册证书 - 新药情报库
2 days ago
通化东宝药业股份有限公司近日发布公告，宣布公司生产的门冬胰岛素注射液已获得印度尼西亚共和国食品药品监督管理局颁发的药品注册证书。